Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.
David Gustafsson
Advertisement
Associate Director, Project Data Manager, AstraZeneca
Articles by David Gustafsson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
2
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
3
Bringing the Voice of Clinical Practice and Patients into Drug Development
4
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
5